Cerenome unit CNSide Diagnostics sets Sept. 30 CNSide business update call
CNSY•CNSide Diagnostics, a wholly owned Cerenome unit, will hold a business update call on Sept. 30, 2026, covering commercial execution for its cerebrospinal fluid diagnostic platform.
1. Call topics
The discussion will address third-party billing, market access, commercial team expansion and broadening the diagnostic testing portfolio. The CNSide platform launched in early 2026.
